Li Y, Kang J, Horwitz M S. RID only, ITGB8 or E3-14.7K only. RID inhibits TRAIL-induced apoptosis when cells are sensitized to TRAIL either by adenovirus infection or treatment with cycloheximide. RID induces the internalization of TRAIL-R1 from the cell surface, as shown by flow cytometry and indirect immunofluorescence for TRAIL-R1. TRAIL-R1 Barnidipine was internalized in distinct vesicles which are very likely to be endosomes and lysosomes. TRAIL-R1 is degraded, as indicated by the disappearance of the TRAIL-R1 immunofluorescence signal. Degradation was inhibited by bafilomycin A1, a drug that prevents acidification of vesicles and the sorting of receptors from late endosomes to lysosomes, implying that Barnidipine degradation occurs in lysosomes. RID was also shown previously to internalize and degrade another death domain receptor, Fas, and to prevent apoptosis through Fas and the TNF receptor. RID was shown previously to force the internalization and degradation of the epidermal growth factor receptor. E1B-19K was shown previously to block apoptosis through Fas, and both E1B-19K and E3-14.7K were found to prevent apoptosis through the TNF receptor. These findings suggest that the receptors for TRAIL, Fas ligand, and TNF play a role in limiting virus infections. The ability of adenovirus to inhibit killing through these receptors may prolong acute and persistent infections. Adenovirus Barnidipine (Ad) has been widely studied as a model for virus replication, gene regulation, oncogenic cell transformation, and immune evasion. Ad infection in cell culture proceeds in well-regulated phases. The immediate-early E1A proteins, derived from the E1A transcription unit, induce transcription of delayed-early genes in the E1B, E2, E3, and E4 transcription units. Viral DNA begins to replicate at about 7 h postinfection (p.i.), and then late, primarily structural genes are expressed. Virions begin to assemble in the cell nucleus at about 1 day p.i. The cells begin to lyse at 2 to 3 3 days p.i. and release virus particles. It is important that the infected cell remain intact during this extended period of infection. Indeed, Ads have Barnidipine evolved proteins that protect infected cells against apoptosis induced by cells and agents of the immune system (reviewed in references 14, 49, 69, 83, 87, 89, and 90). Most of these Ad proteins are encoded by the E3 and E1B transcription units. One such protein, named E3-gp19K, is a membrane glycoprotein localized in the endoplasmic reticulum. E3-gp19K forms a complex Barnidipine with major histocompatibility complex class I antigens, blocks their transport to the cell surface, and prevents killing of infected cells by cytotoxic T lymphocytes (CTL). Three Ad proteins inhibit apoptosis induced by tumor necrosis factor alpha (TNF-) and Fas ligand (FasL; also known as CD95L). These ligands are expressed on activated leukocytes and are also shed in functional form; interact with their cognate receptors, TNF receptor 1 (TNFR1) and Fas (also known as CD95 and ApoI), respectively; and induce apoptosis by activation of caspases. The E3 protein named RID (for receptor internalization and degradation), a complex of the RID and RID proteins (formerly known as E3-10.4K and E3-14.5K), is an integral membrane protein localized primarily on the cell surface (34, 67, 74, 75). RID inhibits apoptosis through the Fas pathway (19, 65, 72) by stimulating the internalization of cell surface Fas into endosomes, which are transported to lysosomes, where Fas is degraded (72). RID also inhibits TNF-induced apoptosis (23, 42). Another E3 protein, a nonmembrane protein named E3-14.7K (78), independently inhibits TNF-induced apoptosis (22, 24, 42). E3-14.7K is also reported to inhibit apoptosis induced through the Fas pathway (13). Finally, the protein named E1B-19K inhibits apoptosis induced through the TNF and Fas pathways (21, 31, 56, 72, 84). TNF and FasL are members of the TNF superfamily. TNFR1 and Fas are members of the TNFR superfamily and contain death domains (reviewed in references 28, 53, 61, and 62). Death domains are conserved protein domains that participate in protein-protein interactions leading to activation of caspases that mediate apoptosis. TNF-related apoptosis-inducing ligand (TRAIL [also known as Apo2L]) is another member of the TNF superfamily that induces apoptosis (51, 58, 85), and two of the TRAIL receptors, TRAIL-R1 (also known as death receptor 4) and TRAIL-R2 (also known as death receptor 5), contain death domains (12, 54, 55, 64, 81). TRAIL and its receptors are expressed on many cell types (25). TRAIL and the TRAIL receptors have been shown to play a role in a number of viral infections. T cells from human immunodeficiency virus-infected patients are killed by.
Categories